173 related articles for article (PubMed ID: 37555948)
1. Biochemical and metabolomic insights into antifungal mechanism of berberine against Candida glabrata.
Gupta P; Gupta H; Tripathi S; Poluri KM
Appl Microbiol Biotechnol; 2023 Oct; 107(19):6085-6102. PubMed ID: 37555948
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
3. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
[TBL] [Abstract][Full Text] [Related]
4. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
5. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanisms of fluconazole resistance in clinical isolates of Candida glabrata].
Shen YZ; Lu HZ; Zhang YX
Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):245-9. PubMed ID: 20450660
[TBL] [Abstract][Full Text] [Related]
7. Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant
Xu Y; Quan H; Wang Y; Zhong H; Sun J; Xu J; Jia N; Jiang Y
Front Cell Infect Microbiol; 2017; 7():491. PubMed ID: 29238700
[No Abstract] [Full Text] [Related]
8. Geraniol eradicates Candida glabrata biofilm by targeting multiple cellular pathways.
Gupta P; Gupta H; Poluri KM
Appl Microbiol Biotechnol; 2021 Jul; 105(13):5589-5605. PubMed ID: 34196746
[TBL] [Abstract][Full Text] [Related]
9. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
[TBL] [Abstract][Full Text] [Related]
10. Milbemycins: more than efflux inhibitors for fungal pathogens.
Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
[TBL] [Abstract][Full Text] [Related]
11. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
[TBL] [Abstract][Full Text] [Related]
12. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
Gohar AA; Badali H; Shokohi T; Nabili M; Amirrajab N; Moazeni M
Mycopathologia; 2017 Apr; 182(3-4):273-284. PubMed ID: 27744635
[TBL] [Abstract][Full Text] [Related]
13. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328
[TBL] [Abstract][Full Text] [Related]
14. The Set1 Histone H3K4 Methyltransferase Contributes to Azole Susceptibility in a Species-Specific Manner by Differentially Altering the Expression of Drug Efflux Pumps and the Ergosterol Gene Pathway.
Baker KM; Hoda S; Saha D; Gregor JB; Georgescu L; Serratore ND; Zhang Y; Cheng L; Lanman NA; Briggs SD
Antimicrob Agents Chemother; 2022 May; 66(5):e0225021. PubMed ID: 35471041
[TBL] [Abstract][Full Text] [Related]
15. Zap1 is required for Candida glabrata response to fluconazole.
Gaspar-Cordeiro A; Afonso G; Amaral C; da Silva SM; Pimentel C
FEMS Yeast Res; 2022 Jan; 22(1):. PubMed ID: 35040997
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates.
Shi G; Shao J; Wang T; Wu D; Wang C
Biomed Pharmacother; 2017 Sep; 93():709-712. PubMed ID: 28700974
[TBL] [Abstract][Full Text] [Related]
17. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
18. A Transcriptomics Approach To Unveiling the Mechanisms of
Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666
[No Abstract] [Full Text] [Related]
19. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
[TBL] [Abstract][Full Text] [Related]
20. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
